Skip to main content
Equibles

Jess Fye

Analyst

J.P. Morgan

Equibles does not estimate personal net worth.

About Jess Fye

Jess Fye is recorded as Analyst at J.P. Morgan. Jess Fye has spoken on 1 earnings call across 1 company, most recently for NovoCure Ltd on July 23, 2026. The companies whose calls Jess Fye spoke on are classified in the Healthcare sector.

Jess Fye on recent calls

“I was trying to infer from your comments about the mix of, you know, one-time prescribers versus repeat prescribers so far, but I figured maybe just to ask you directly, like, what's the total number of prescribers who are sourcing those, you know, 418 PACS scripts in the quarter?”
Analyst — J.P. Morgan, Q2 2026 Earnings Conference Call ·

Affiliation history

  • J.P. Morgan

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity